Do Peptides Cause Cancer?
Peptides and cancer: why growth-hormone and blood-vessel peptides raise theoretical concerns, what evidence exists, and who is warned off.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
There is no evidence that peptides as a class cause cancer, but some carry specific theoretical risks. Peptides that raise growth hormone and IGF-1 (sermorelin, CJC-1295, ipamorelin, MK-677, tesamorelin) could in theory speed growth of an existing tumour, which is why people with active or recent cancer are warned off. BPC-157 and TB-500 promote new blood vessels in animal studies — useful for wounds, a concern for tumours. Melanotan II can darken and change moles, which complicates melanoma checks. Long-term human data are missing for most research peptides. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
| Peptide group | Theoretical concern |
|---|---|
| GH-raising peptides | Higher IGF-1 linked to tumour growth |
| BPC-157 / TB-500 | Promote blood-vessel growth |
| Melanotan II | Changing moles; masks melanoma signs |
| GLP-1 drugs | Thyroid C-cell tumours in rodents; label warning for MTC/MEN2 history |
Related topics
community guides:
More confessions from the archive
Community Q&A
- Do peptides cause cancer?
- No peptide has been shown to cause cancer in humans, but growth-promoting peptides could theoretically worsen an existing cancer and are avoided by people with cancer history.
- Does BPC-157 cause cancer?
- There is no human evidence that it does. Its pro-blood-vessel effect in animals is a theoretical concern for anyone with a tumour.
- Can melanotan cause skin cancer?
- A causal link is unproven, but it darkens and can change moles, so new or changing moles need a dermatologist.
- Does Peptide Confessions give dosing?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.